Dr. Brandon M. Henry

Dr. Brandon M. Henry is a physician-scientist, therapeutic development leader, and founder of Aurelix Bio, focused on advancing genetic medicines for rare and ultra-rare diseases. His expertise spans gene therapy, genome editing, and RNA therapeutics, with leadership experience from translational research through IND clearance and first-in-human studies.

Formerly Medical Director of IQVIA’s Cell & Gene Therapy Center of Excellence, he holds leadership roles with the FOXG1 Research Foundation, CACNA1A Foundation, and Raiden Science Foundation. He has authored more than 400 peer-reviewed publications and has been recognized as a Clarivate Highly Cited Researcher and among the Stanford/Elsevier Top 2% Scientists.